| Aβ | β-amyloid. |
| AChE | Acetyl cholinesterase. |
| ACR | Acrylamide. |
| AD | Alzheimer disease. |
| AGE | Advanced glycation end-product. |
| ASD | Amorphous solid dispersion. |
| ATRA | All-trans retinoic acid. |
| BBB | Blood–brain barrier. |
| BDNF | Brain-derived neurotrophic factor. |
| BP | Blood pressure. |
| BuChE | Butyrylcholinesterase. |
| Cmax | Maximum concentration in plasma. |
| CA | Cornus ammonis. |
| CAAdP | Cellulose acetate adipate propionate. |
| Ca2+-EA-ALG NP | Ellagic acid encapsulated in calcium-alginate nanoparticles. |
| CAT | Catalase. |
| Ch/β-GP | Chitosan/β-glycerophosphate. |
| CMCAB | Carboxymethyl cellulose acetate butyrate. |
| CNS | Central nervous system. |
| COX | Cyclooxygenase. |
| Cup | Cuprizone. |
| cyt C | Cytochrome c. |
| DG | Dentate gyrus. |
| d-gal | d-galactose. |
| DOX | Doxorubicin. |
| EA | Ellagic acid. |
| EA-NP | Ellagic acid nanoparticle. |
| EEG | Electroencephalographic. |
| eNOS | Endothelial nitric oxide synthase. |
| EPM | Elevated plus-maze. |
| Erβ | Estrogen receptor β. |
| ET | Ellagitannin. |
| FST | Forced swimming test. |
| GABA | γ-aminobutyric acid type. |
| GFAP | Glial fibrillary acidic protein. |
| GPx | Glutathione peroxidase. |
| GSH | Reduced glutathione. |
| HPMCAS | Hydroxy-propyl-methyl cellulose acetate succinate. |
| HPC | Hippocampus/hippocampal. |
| HO-1 | Heme oxygenase-1. |
| iNOS | Nitric oxide synthase. |
| LDH | Lactate dehydrogenase. |
| LPO | Lipid peroxidation. |
| LTP | Long-term potentiation. |
| MAO | Monoamine oxidase. |
| MAPK | Mitogen-activated protein kinase. |
| MDA | Malondialdehyde. |
| MFB | Medial forebrain bundle. |
| Nrf2 | Nuclear factor erythroid 2-related factor-2. |
| OLG | Oligodendrocyte. |
| PCL | Poly(ε-caprolactone). |
| PCO | Protein carbonylation. |
| PCPA | p-chlorophenylalanine. |
| PD | Parkinson disease. |
| PDI | Protein disulfide isomerase. |
| PI3K | Phosphoinositide 3-kinase. |
| PON-1 | Paraoxonase. |
| PTZ | Pentylenetetrazol. |
| PVP | Polyvinylpyrrolidone. |
| RAGE | Receptor of advanced glycation end-products. |
| ROS | Reactive oxygen species. |
| SA | Sodium arsenite. |
| SAD | Sporadic Alzheimer disease. |
| SNc | Substantia nigra pars compacta. |
| SNO | S-nitrosylation. |
| SNO-PDI | S-nitrosylation of protein disulfide isomerase. |
| SOD | Superoxide dismutase. |
| SSB | Single-strand break. |
| STZ | Streptozotocin. |
| TAC | Total antioxidant capacity. |
| TBI | Traumatic brain injury. |
| TCDD | 2,3,7,8-tetrachlorodibenzo-p-dioxin. |
| ThT | Thioflavin T. |
| TOS | Total oxidant status. |
| TST | Tail suspension test. |
| β-gal | β-galactosidase. |
| 5-HT | 5-hydroxytryptamine. |
| 6-OHDA | 6-hydroxydopamine. |